Drugs / Inactivated Poliovirus Vaccine
Inactivated Poliovirus Vaccine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT03286803 | Aug 2017 → Apr 2019 | poliomyelitis | Aga Khan University | Unknown | No outcome recorded |
| Phase 4 | NCT01847872 | Jul 2013 → Apr 2015 | poliomyelitis | London School of Hygiene and Tropical Medicine | Completed | Mixed |
| Phase not applicable1 trial | ||||||
| — | NCT00260312 | Aug 2001 → Jan 2003 | — | Pan American Health Organization | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT03614533 Comparator | Dec 2018 → Aug 2019 | typhoid fever | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 3 | NCT05386810 Comparator | Nov 2020 → Oct 2022 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
| Phase 4 | NCT03202719 Comparator | Nov 2017 → Oct 2019 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 4 | NCT01680679 Comparator | May 2012 → May 2014 | influenza | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Poliovirus vaccine | “A Phase 4, Randomized Trial to Assess the Safety and Immunogenicity of Inactivated Poliovirus Vaccine When Given Concomitantly With Measles and Rubella Combined Vaccine and...” NCT01847872 ↗6“The purpose of this study was to evaluated the effectiveness of inactivated poliovirus vaccine at a vaccine schedule that is commonly used in developing countries.” NCT00260312 ↗ “Inactivated Poliovirus Vaccine - control vaccine produced by Sanofi.” NCT05386810 ↗ |
| Known as | fIPV | “Fractional dose (one-fifth of full intramuscular dose) of inactivated poliovirus vaccine (fIPV) administered intradermally is used as IPV dose-sparing strategy.” PMID 32798224 ↗ Apr 2021 |
| Known as | Inactivated Polio Vaccine | “Inactivated Polio Vaccine (IPV)” NCT01847872 ↗ |
| Known as | IPV | “This was a follow-up study conducted in 2020 assessing changes in levels of type 2 poliovirus-neutralizing antibodies 2 years postimmunization in children who received...” PMID 37368349 ↗ Jan 20244“Inactivated poliovirus vaccine (IPV) at 14 weeks and 18 months of age” NCT03202719 ↗ “Inactivated poliovirus vaccine (IPV), trivalent” NCT01680679 ↗ “Inactivated Poliovirus Vaccine (IPV)” NCT03614533 ↗ “Inactivated Polio Vaccine (IPV)” NCT01847872 ↗ |
| Modality | Vaccine | “Inactivated poliovirus vaccine (IPV), trivalent” NCT01680679 ↗ |
| Route | Intramuscular | “full intramuscular or fractional intradermal dose” PMID 27364568 ↗ Jun 2016 |